Search Results for “biotechnology” – Page 22 – media

Need Natural Plant Extracts? Here are 4 Suppliers!

Natural plant extracts have the potential to benefit the health of a person in numerous ways without producing any significant adverse effects. They are added to a number of medicinal preparations as well as cosmetics to enhance their efficacy.
- Source: Ddu
- 1,624
- September 6, 2018
Company Insight Natural plant extracts
Healthcare Products & Food Additives Suppliers for International Companies

Ddu (Drugdu.com) offers a host of healthcare-related products on its global leading pharmaceutical and medical devices platform. One is spoilt for choice when it comes to the number of suppliers that are available on the website. Along with quantity, Ddu doesn’t compromise on quality and provides its customers with the best healthcare products & food additives suppliers.
- Source: Ddu
- 2,059
- September 6, 2018
Company Insight healthcare products & food additives
4 Healthcare Products & Food Additives Suppliers on Drugdu.com

Food additives are substances added to food products for enhancing the taste, appearance and flavor. The US-FDA consider food additives as GRAS (generally recognized as safe). According to Mordor Intelligence, there occurred a rapid rise in the food additives market with an anticipated annual growth rate of 6% during from 2018-2023.
- Source: Ddu
- 1,065
- September 5, 2018
Company Insight Food additives
3 Medical Diagnostic Equipment Suppliers

With advancements in the medical field, new, rare or common diseases seem to spring up frequently. To outpace the ever-growing illnesses, technology has helped the medical fraternity enormously to diagnose and tackle them.
- Source: Ddu
- 648
- September 4, 2018
Company Insight medical diagnostic equipment
Assembly Biosciences Initiates Phase 2a Trial for its Lead HBV Core Inhibitor

U.S. based public biotechnology company, Assembly Bioscience revealed the launch of two randomized control phase 2a trials for its leading hepatitis B core inhibitor in a press release.
- Source: Healio
- 1,000
- July 17, 2018
Clinical Trials hepatitis B
Torque’s T cell ‘Backpacks’ Show Promising Results Against Solid Tumors

Gilead’s Yescarta and Novartis’ Kymriah garnered a lot of interest among T-cell therapies after producing high response rates in patients with lymphoma and leukemia. However, the same has not been true for this technology in cases of solid tumors. In this novel procedure, patients’ immune-boosting T cells are extracted and engineered to target and destroy cancer cells.
- Source: FierceBiotech
- 1,116
- July 11, 2018
cancer Researches T-cell therapies
Alta Partners Raise $130 Million Venture Capital for Biotech Development

San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
- Source: FierceBiotech
- 619
- June 14, 2018
Company Insight healthcare technologies and innovations
Anti-Aging Stratup Juvenescence Raises $50 Million for New Project

The Isle of Man-based anti-aging biotech company is focusing on developing therapeutics for human longevity by partnering, creating, and investing in companies with anti-aging related projects.
- Source: Fierce Biotech
- 480
- June 13, 2018
biotech Company Insight funding
Rise in China’s Global Pharma Market up to $175 billion by 2022 – Market Prediction

Though the US stands first in the race in terms of sales and growth, it is highly believed that China would reach the peak in the pharma market by 2022. At present, since there has been a decrease in public health funding, there has been a slight fall in pharmerging countries like Brazil, Russia, India and China (BRIC). But it is believed that the condition of these pharmerging countries will improve in the next five years [1].
- Source: Ddu
- 822
- May 24, 2018
China Market Views pharmaceutical drugs
Third Rock Ventures Launches Cedilla Therapeutics with $56 Million Investment to Target Protein Stability Using Small Molecule Therapeutics

Company is targeting upstream aspects of native protein degradation pathways to develop new therapies for cancer
- Source: drugdu
- 703
- April 26, 2018
Market Views Series small molecule

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.